Study of RP-6306 With Gemcitabine in Advanced Solid Tumors

NCT05147272 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

67

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decided to terminate the study

Conditions

Adult Solid Tumor

Interventions

DRUG: RP-6306 (oral PKMYT1 inhibitor)

Sponsor

Debiopharm International SA

Collaborators

[object Object]